Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.3650 (-0.81%) ($7.3650 - $7.3650) on Fri. Feb. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5% (three month average) | RSI | 62 | Latest Price | $7.3650(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.5% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(50%) IBB(37%) IWC(30%) ARKG(28%) IWO(27%) | Factors Impacting IOVA price | IOVA will decline at least -2.5% in a week (0% probabilities). VIXM(-13%) BND(-10%) XLP(-9%) UUP(-9%) USO(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.5% (StdDev 5%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.47 | 5 Day Moving Average | $7.82(-5.82%) | 10 Day Moving Average | $7.89(-6.65%) | 20 Day Moving Average | $7.47(-1.41%) | To recent high | -17.1% | To recent low | 31.3% | Market Cap | $1.078b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |